A

Angimmune

MD - Rockville
Biotechnology
WebsiteLinkedIn

Focus: Anti T cell Immunotoxin

Angimmune is a life sciences company focused on Anti T cell Immunotoxin.

Oncology
Employees
5000+
Open Jobs
0

Pipeline & Clinical Trials

A-dmDT390-bisFv
Melanoma
Phase 1/2
Clinical Trials (1)
NCT01888081A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma
Phase 1/2
A-dmDT390-bisFv
Stage IV Melanoma
Phase 1/2
Clinical Trials (1)
NCT02990416A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma
Phase 1/2
A-dmDT390-bisFv
Mycosis Fungoides
Phase 2
A-dmDT390-bisFv
T-cell Lymphomas
Phase 2
Clinical Trials (1)
NCT00611208A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)
Phase 2

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts
Portfolio: 3 clinical trials